Gordon Muir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gordon Muir has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Thomas Cohen
Guy's and St Thomas' Hospitals NHS Foundation Trust, King's College London, UK
2 shared publications - Arnauld Villers
Department of Urology, Lille University Hospital, 59000 Lille, France
2 shared publications - Caroline M. Moore
Department of Urology University College London Hospitals NHS Foundation Trust London UK
2 shared publications - Mark Emberton
Division of Surgery and Interventional Science, University College London, London WC1E 6BT, UK
2 shared publications - Matthew Deacon
Urology Department, King’s College Hospital, London, UK
2 shared publications - Nicholas Raison
School of Biomedical Engineering & Imaging Sciences King's College London London UK
2 shared publications
Latest Publications
- Open Access
- 27 June 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (10) , 6843-6845
Quality in clinical research: an observational study of randomisation techniques in urological and general surgical studies
An abstract is unavailable. This article is available as a PDF only.
- 27 June 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (10) , 6843-6845
Open AccessQuality in clinical research: an observational study of randomisation techniques in urological and general surgical studies
An abstract is unavailable. This article is available as a PDF only.
- Open Access
Quality in Clinical Research: An Observational Study of Randomisation Techniques in Urological and General Surgical Studies
Objectives To quantitatively test the quality of randomised controlled trials reported to international scientific meetings through a critical analysis of randomisation outcomes. Design and Main Outcome Measures All randomised controlled trials presented at international surgical and urological congresses using simple randomisation were identified. Primary analysis of randomisation technique was performed by comparing the observed and expected numbers of trials with equal numbers of participants in each arm. Sensitivity analyses compared study design, type of study and presence of external sponsorship. All abstracts were assessed according to the CONSORT for reporting randomised trials in journal and conference abstracts checklist. Results 345 studies met the inclusion criteria. 148 studies reported simple randomisation to allocate 26,510 patients. Randomisation technique could not be identified in 104 studies. Primary and all secondary analyses demonstrated a probability of pConclusions It is extremely unlikely that simple randomisation was performed as reported in a significant proportion of the 148 RCTs in this study. These results raise concerning questions of the veracity and reliability of current medical research. There needs to be a greater awareness of the potential for methodological inaccuracy and error.
Open AccessQuality in Clinical Research: An Observational Study of Randomisation Techniques in Urological and General Surgical Studies
Objectives To quantitatively test the quality of randomised controlled trials reported to international scientific meetings through a critical analysis of randomisation outcomes. Design and Main Outcome Measures All randomised controlled trials presented at international surgical and urological congresses using simple randomisation were identified. Primary analysis of randomisation technique was performed by comparing the observed and expected numbers of trials with equal numbers of participants in each arm. Sensitivity analyses compared study design, type of study and presence of external sponsorship. All abstracts were assessed according to the CONSORT for reporting randomised trials in journal and conference abstracts checklist. Results 345 studies met the inclusion criteria. 148 studies reported simple randomisation to allocate 26,510 patients. Randomisation technique could not be identified in 104 studies. Primary and all secondary analyses demonstrated a probability of pConclusions It is extremely unlikely that simple randomisation was performed as reported in a significant proportion of the 148 RCTs in this study. These results raise concerning questions of the veracity and reliability of current medical research. There needs to be a greater awareness of the potential for methodological inaccuracy and error.
- Open Access
- 19 October 2022
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 35 (3) , 267-268
Reply to Morris et al. re: ‘The medical evidence on non-therapeutic circumcision of infants and boys—setting the record straight’
- 19 October 2022
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 35 (3) , 267-268
Open AccessReply to Morris et al. re: ‘The medical evidence on non-therapeutic circumcision of infants and boys—setting the record straight’
- 8 January 2022
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 35 (3) , 256-263
What is the medical evidence on non-therapeutic child circumcision?
Non-therapeutic circumcision refers to the surgical removal of part or all of the foreskin, in healthy males, where there is no medical condition requiring surgery. The arguments for and against this practice in children have been debated for many years, with conflicting and conflicted evidence presented on both sides. Here, we explore the evidence behind the claimed benefits and risks from a medical and health-related perspective. We examine the number of circumcisions which would be required to achieve each purported benefit, and set that against the reported rates of short- and long-term complications. We conclude that non-therapeutic circumcision performed on otherwise healthy infants or children has little or no high-quality medical evidence to support its overall benefit. Moreover, it is associated with rare but avoidable harm and even occasional deaths. From the perspective of the individual boy, there is no medical justification for performing a circumcision prior to an age that he can assess the known risks and potential benefits, and choose to give or withhold informed consent himself. We feel that the evidence presented in this review is essential information for all parents and practitioners considering non-therapeutic circumcisions on otherwise healthy infants and children.
- 8 January 2022
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 35 (3) , 256-263
What is the medical evidence on non-therapeutic child circumcision?
Non-therapeutic circumcision refers to the surgical removal of part or all of the foreskin, in healthy males, where there is no medical condition requiring surgery. The arguments for and against this practice in children have been debated for many years, with conflicting and conflicted evidence presented on both sides. Here, we explore the evidence behind the claimed benefits and risks from a medical and health-related perspective. We examine the number of circumcisions which would be required to achieve each purported benefit, and set that against the reported rates of short- and long-term complications. We conclude that non-therapeutic circumcision performed on otherwise healthy infants or children has little or no high-quality medical evidence to support its overall benefit. Moreover, it is associated with rare but avoidable harm and even occasional deaths. From the perspective of the individual boy, there is no medical justification for performing a circumcision prior to an age that he can assess the known risks and potential benefits, and choose to give or withhold informed consent himself. We feel that the evidence presented in this review is essential information for all parents and practitioners considering non-therapeutic circumcisions on otherwise healthy infants and children.
- Open Access
- 6 April 2021
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 114 (5) , 244-245
Medicolegal consequences of altered COVID-19 vaccine administration
- 6 April 2021
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 114 (5) , 244-245
Open AccessMedicolegal consequences of altered COVID-19 vaccine administration
- 1 January 2020
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 46 (4) , 262-273
Prostatic abscess: A systematic review of current diagnostic methods, treatment modalities and outcomes
Objective: Prostatic abscesses (PAs) are an uncommon urologic presentation with widely varying approaches in their diagnoses and management. This study, therefore, aims to systematically review the literature of PAs to identify common clinical presentations, evaluate currently utilized diagnostic and treatment modalities, and assess their outcomes. Material and methods: A systematic review of the literature was performed using the MEDLINE and EMBASE databases, from January 1968 to June 2019. Outcome measures extracted from identified articles included age, the underlying disease, identified pathogens, diagnostic tool utilized, treatment used, and various subsequent clinical outcomes. Results: The literature search yielded 683 articles, with a final twelve included in the review, representing a total of 210 patients. Transrectal ultrasonography (TRUS) was the most commonly used imaging tool used to identify PAs in all twelve studies. The PAs were treated with conservative antibiotic treatment in seven studies. Transurethral resection of the prostatic abscess (TURP) was utilized in eight studies with an average abscess size of 3.87 cm (3.0-4.0 cm) and with an average hospital stay of 10.22 days in those undergoing TURP. Transperineal aspiration was seen in five studies and offered a less invasive treatment modality. Finally, TRUS-guided needle aspiration was seen in seven studies with an average hospital stay of 23.25 days. This was the longest of any identified modalities with an additional high rate of abscess recurrence. Conclusion: Diagnosis and treatment practices of PAs remain widely varied in the literature due to a lack of clear guidelines. Based on the current evidence, we provide recommendations of treatment based on abscess size, patient age, and clinical condition. While smaller abscesses may be suited to antibiotic or TRUS-guided aspiration, transurethral approaches should be considered for larger and more complex abscesses. However, the current evidence remains poor with further research required to determine the optimum treatment modalities for patients. Cite this article as: Khudhur H, Brunckhorst O, Muir G, Jalil R, Khan A, Ahmed K. Prostatic abscess: A systematic review of current diagnostic methods, treatment modalities and outcomes. Turk J Urol 2020; 46(4): 262-73.
- 1 January 2020
- Published by AVES YAYINCILIK A.Ş. in Urology Research and Practice
- Vol. 46 (4) , 262-273
Prostatic abscess: A systematic review of current diagnostic methods, treatment modalities and outcomes
Objective: Prostatic abscesses (PAs) are an uncommon urologic presentation with widely varying approaches in their diagnoses and management. This study, therefore, aims to systematically review the literature of PAs to identify common clinical presentations, evaluate currently utilized diagnostic and treatment modalities, and assess their outcomes. Material and methods: A systematic review of the literature was performed using the MEDLINE and EMBASE databases, from January 1968 to June 2019. Outcome measures extracted from identified articles included age, the underlying disease, identified pathogens, diagnostic tool utilized, treatment used, and various subsequent clinical outcomes. Results: The literature search yielded 683 articles, with a final twelve included in the review, representing a total of 210 patients. Transrectal ultrasonography (TRUS) was the most commonly used imaging tool used to identify PAs in all twelve studies. The PAs were treated with conservative antibiotic treatment in seven studies. Transurethral resection of the prostatic abscess (TURP) was utilized in eight studies with an average abscess size of 3.87 cm (3.0-4.0 cm) and with an average hospital stay of 10.22 days in those undergoing TURP. Transperineal aspiration was seen in five studies and offered a less invasive treatment modality. Finally, TRUS-guided needle aspiration was seen in seven studies with an average hospital stay of 23.25 days. This was the longest of any identified modalities with an additional high rate of abscess recurrence. Conclusion: Diagnosis and treatment practices of PAs remain widely varied in the literature due to a lack of clear guidelines. Based on the current evidence, we provide recommendations of treatment based on abscess size, patient age, and clinical condition. While smaller abscesses may be suited to antibiotic or TRUS-guided aspiration, transurethral approaches should be considered for larger and more complex abscesses. However, the current evidence remains poor with further research required to determine the optimum treatment modalities for patients. Cite this article as: Khudhur H, Brunckhorst O, Muir G, Jalil R, Khan A, Ahmed K. Prostatic abscess: A systematic review of current diagnostic methods, treatment modalities and outcomes. Turk J Urol 2020; 46(4): 262-73.
- 23 April 2019
- Published by Oxford University Press (OUP) in Sexual Medicine Reviews
- Vol. 8 (1) , 158-180
Systematic Review of Surgical and Nonsurgical Interventions in Normal Men Complaining of Small Penis Size
Introduction: Evidence on penile enhancement interventions is lacking. Nonetheless, many non–evidence-based solutions are readily available.Aim: To investigate enhancement and nonenhancement interventions in men without penile abnormalities seeking to increase penis size.Methods: We performed a systematic review with no time restrictions adhering to the PRISMA guidelines. Studies with fewer than 10 cases or including men with organic penile pathologies or previous penile surgeries were excluded.Main Outcome Measures: When available, treatment efficacy was evaluated based on patient satisfaction, penile size increase, and complications.Results: We included 17 studies, assessing a total of 21 interventions in 1,192 men screened, with 773 followed up after nonsurgical (n = 248) or surgical (n = 525) treatment. The quality of the studies was poor in terms of methodology for patient selection and outcomes assessment. The vast majority of series reported normal penile size. Among nonsurgical treatments, extenders increased flaccid length (but by <2 cm), injectables increased girth but were associated with a high complication rate, and vacuum devices did not increase size. Surgical interventions included suspensory ligament incision (the most used method; n = 12), tissue grafting (autologous, n = 2; dermal fat, n = 3, ex vivo, n = 2), flaps (n = 2), and penile disassembly (n = 1). Some men reported a significant size increase; however, complications were not infrequent, and none of the techniques was externally validated. When provided, counseling was effective, with the majority of men coming to understand that their penis was normal and unwilling to undergo any further treatment.Conclusion: Treatment of small penis in normal men is supported by scant, low-quality evidence. Structured counseling should be always performed, with extenders eventually used by those still seeking enhancement. Injectables and surgery should remain a last option, considered unethical outside of clinical trials.
- 23 April 2019
- Published by Oxford University Press (OUP) in Sexual Medicine Reviews
- Vol. 8 (1) , 158-180
Systematic Review of Surgical and Nonsurgical Interventions in Normal Men Complaining of Small Penis Size
Introduction: Evidence on penile enhancement interventions is lacking. Nonetheless, many non–evidence-based solutions are readily available.Aim: To investigate enhancement and nonenhancement interventions in men without penile abnormalities seeking to increase penis size.Methods: We performed a systematic review with no time restrictions adhering to the PRISMA guidelines. Studies with fewer than 10 cases or including men with organic penile pathologies or previous penile surgeries were excluded.Main Outcome Measures: When available, treatment efficacy was evaluated based on patient satisfaction, penile size increase, and complications.Results: We included 17 studies, assessing a total of 21 interventions in 1,192 men screened, with 773 followed up after nonsurgical (n = 248) or surgical (n = 525) treatment. The quality of the studies was poor in terms of methodology for patient selection and outcomes assessment. The vast majority of series reported normal penile size. Among nonsurgical treatments, extenders increased flaccid length (but by <2 cm), injectables increased girth but were associated with a high complication rate, and vacuum devices did not increase size. Surgical interventions included suspensory ligament incision (the most used method; n = 12), tissue grafting (autologous, n = 2; dermal fat, n = 3, ex vivo, n = 2), flaps (n = 2), and penile disassembly (n = 1). Some men reported a significant size increase; however, complications were not infrequent, and none of the techniques was externally validated. When provided, counseling was effective, with the majority of men coming to understand that their penis was normal and unwilling to undergo any further treatment.Conclusion: Treatment of small penis in normal men is supported by scant, low-quality evidence. Structured counseling should be always performed, with extenders eventually used by those still seeking enhancement. Injectables and surgery should remain a last option, considered unethical outside of clinical trials.
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e651-e652
Penile prosthesis implantation preserves and may increase penile size irrespective of implant type
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e651-e652
Penile prosthesis implantation preserves and may increase penile size irrespective of implant type
- 1 April 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 189 (4S)
1999 MULTICENTRE PROSPECTIVE STUDY OF THE EVOLVE™ DUAL 150W LASER FOR BLADDER OUTFLOW OBSTRUCTION – 1 YEAR FOLLOW UP
- 1 April 2013
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 189 (4S)
1999 MULTICENTRE PROSPECTIVE STUDY OF THE EVOLVE™ DUAL 150W LASER FOR BLADDER OUTFLOW OBSTRUCTION – 1 YEAR FOLLOW UP